Online Database of Chemicals from Around the World

Pamabrom
[CAS# 606-04-2]

List of Suppliers
Simagchem Corporation China Inquire  
+86 13806087780
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2008
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
Medilink Pharmachem India Inquire  
+91 (79) 3007-0133
exports@medilinkpharma.com
Chemical distributor since 1996
chemBlink standard supplier since 2014
Leap Chem Co., Ltd. China Inquire  
+86 (852) 3060-6658
market19@leapchem.com
QQ chat
Chemical manufacturer since 2006
chemBlink standard supplier since 2015
Shanghai Yuanye Bio-Technology Co., Ltd. China Inquire  
+86 (21) 6184-5781
+86 13585604150
shyysw053@163.com
QQ chat
Chemical manufacturer since 2009
chemBlink standard supplier since 2016
Guangzhou Green Cross Pharmaceutical Co., Ltd. China Inquire  
+86 (20) 8222-0238
wangsy@m-pharma.com.cn
Chemical manufacturer since 1991
chemBlink standard supplier since 2024
Papchem Lifesciences India Inquire  
9061328401
bd@papchemlifesciences.com
Chemical manufacturer since 2021
chemBlink standard supplier since 2024
Complete supplier list of Pamabrom
Identification
Classification Analytical chemistry >> Analytical reagent >> Ion chromatography reagent
Name Pamabrom
Synonyms 2-Amino-2-methylpropanol 8-bromotheophyllinate
Molecular Structure CAS # 606-04-2, Pamabrom, 2-Amino-2-methylpropanol 8-bromotheophyllinate
Molecular Formula C7H7BrN4O2.C4H11NO;C11H18BrN5O3
Molecular Weight 348.20
CAS Registry Number 606-04-2
EC Number 210-103-4
SMILES CC(C)(CO)N.CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Br
Properties
Solubility 10 mM (DMSO)
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H302    Details
Precautionary Statements P264-P270-P301+P317-P330-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
SDS Available
up Discovory and Applicatios
The diuretic pamabrom was discovered in the mid-20th century and has since been widely used in medical treatment. Originally synthesized to treat fluid retention disorders, pamabrom's efficacy lies in its ability to increase urine output without significantly altering electrolyte balance. This property makes it valuable in treating conditions such as menstrual-related edema and some forms of bloating.

Pamabrom's mechanism of action involves stimulation of renal tubular function, thereby promoting the excretion of excess fluid and reducing swelling. Unlike some diuretics that can cause potassium deficiency, pamabrom generally maintains electrolyte levels within the normal range, enhancing its safety for short-term therapeutic use.

In addition to its medical uses, pamabrom is used in pharmaceutical formulations designed to relieve symptoms of premenstrual syndrome (PMS) and associated menstrual discomfort. Its inclusion in over-the-counter medications highlights its accessibility and widespread acceptance among consumers seeking relief from temporary fluid retention.

Research is ongoing to optimize pamabrom's efficacy and explore its potential applications in related therapeutic areas. As the understanding of its pharmacological properties continues to evolve, pamabrom remains a key component in the management of diseases where fluid balance regulation is critical.
Market Analysis Reports
List of Reports Available for Pamabrom
Related Products
Palonosetron hydrochloride  (R,R)-Palonosetron Hydrochloride  Palonosetron Impurity 18  Palonosetron-N-oxide  Palonosetron Related Compound B  Palonosetron Related Compound E  Palosuran  Palovarotene  Palustrol  Palvanil  Pamapimod  Pamidronate disodium salt  Pamidronic acid  Pamoic acid  Panaxadiol  Panaxatriol  Panaxydiol  Panaxydol  Pancreatin  Pancuronium bromide